| Structure | Chemical Name | CAS | MF |
|
clitocine
|
105798-74-1
|
C9H13N5O6
|
|
Aziridine, 2-(4-nitrophenyl)-
|
105799-01-7
|
C8H8N2O2
|
|
4-Chloro-6-fluoro-2H-benzopyran-3-carboxaldehyde
|
105799-69-7
|
C10H6ClFO2
|
|
Ethyl 8-fluoro-4H-(1)-benzopyrano(4 3-b&
|
105799-70-0
|
C14H11FO3S
|
|
6-Fluoro-2,2-dimethylchroman-4-one
|
105799-73-3
|
C11H11FO2
|
|
4H-4-phenylthieno-(3,2-C)-(1)-benzopyran-2-carboxylate
|
105799-78-8
|
|
|
8-Fluoro-4H-thieno[3,2-c]chromene-2-carboxylic acid
|
105799-81-3
|
C12H7FO3S
|
|
Acetamide, N-(2,3-dihydro-2-oxo-6-benzothiazolyl)- (9CI)
|
105800-72-4
|
C9H8N2O2S
|
|
9-hydroxyestrone-11-nitrate
|
105801-89-6
|
C18H21NO6
|
|
3'-(2,2,5,5-tetramethyl-3-pyrroline-1-oxyl-3-carbonyl)amino-3'-deoxyguanosine 5'-diphosphate
|
105802-04-8
|
|
|
Chrysene, 5-methyl-6-nitro-
|
105802-11-7
|
|
|
Ethyl chloroformate, [carboxyl-14C]
|
105802-19-5
|
C3H5ClO2
|
|
4-Di-2-Asp
|
105802-46-8
|
C18H23IN2
|
|
2-methylestra-4,9-dien-3-one-17-ol
|
105802-53-7
|
|
|
3-(2-Oxo-acetyl)-benzonitrile
|
105802-54-8
|
C9H5NO2
|
|
menthyl 3-(2-pyridylsulfinyl)acrylate
|
105802-70-8
|
C18H25NO3S
|
|
H-Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH
|
105802-82-2
|
C51H100N22O11
|
|
H-Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys-OH
|
105802-84-4
|
C56H103N17O16
|
|
splenotritin
|
105803-00-7
|
C17H33N7O6
|
|
5-Bromo-6-chloro-2-methylpyrimidin-4-ol
|
105806-11-9
|
C5H4BrClN2O
|
|
4,6-Dichloro-5-fluoro-2-methylpyrimidine
|
105806-13-1
|
C5H3Cl2FN2
|
|
4(1H)-PyriMidinone, 6-chloro-5-fluoro-2-Methyl-
|
105806-14-2
|
C5H4ClFN2O
|
|
ethyl 2-(4-hydroxy-2,3-dihydro-1H-inden-1-yl)acetate
|
105806-56-2
|
C13H16O3
|
|
Efegatran
|
105806-65-3
|
C21H32N6O3
|
|
2-Methyl-7-nitro-2H-1,4-benzothiazin-3(4H)-one, 97%
|
105807-71-4
|
C9H8N2O3S
|
|
7-Amino-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one
|
105807-79-2
|
C9H10N2O2
|
|
6-Amino-2-methyl-2H-1,4-benzoxazin-3(4H)-one
|
105807-80-5
|
C9H10N2O2
|
|
7-Amino-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one
|
105807-83-8
|
C10H12N2O2
|
|
6-Amino-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one
|
105807-84-9
|
C10H12N2O2
|
|
Amine-terminated magnetic particles
|
105808-72-8
|
|
|
Carboxy-terminated magnetic particles
|
105808-73-9
|
|
|
SPECTRASYNQ 1621
|
105809-15-2
|
C6H12D6N3P3
|
|
N(6)-2-(4-azido-3-iodophenyl)ethyladenosine
|
105811-49-2
|
C18H19IN8O4
|
|
1,2-Dihydro-2-(iodomethyl)-naphthalene
|
105812-53-1
|
C11H11I
|
|
(3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine
|
105812-81-5
|
C13H18FNO
|
|
phenyl (3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- fluorophenyl)piperidine-1-carboxylate compound
|
105812-85-9
|
C26H24FNO5
|
|
cis-Paroxetine hydrochloride
|
105813-04-5
|
C19H20FNO3.ClH
|
|
Paroxetine EP IMpurity E
|
105813-05-6
|
C19H20FNO3
|
|
Paroxetine Impurity 46
|
105813-07-8
|
C19H20FNO3
|
|
trans N-Benzyl Paroxetine
|
105813-14-7
|
C26H26FNO3
|
|
trans-(-)-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-phenyl-1-(phenylMethyl)piperidine Hydrochloride
|
105813-39-6
|
C26H27NO3.ClH
|
|
Defluoro N-Benzyl Paroxetine
|
105813-40-9
|
C26H27NO3
|
|
hupehenisine
|
105814-56-0
|
C27H41NO3
|
|
barbourgenin
|
105815-87-0
|
C27H44O4
|
|
apigenin-7-O-(6''-O-4-coumaroyl)-beta-glucopyranoside
|
105815-90-5
|
C30H26O12
|
|
4''-O-(4-Hydroxy-E-cinnamoyl)cosmosiin
|
105815-91-6
|
C30H26O12
|
|
D-Norleucine, 2-methyl- (9CI)
|
105815-95-0
|
C7H15NO2
|
|
L-Norleucine, 2-methyl- (9CI)
|
105815-96-1
|
C7H15NO2
|
|
Nateglinide
|
105816-04-4
|
C19H27NO3
|
|
L-Nateglinide
|
105816-05-5
|
C19H27NO3
|
|
D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis-
|
105816-06-6
|
C19H27NO3
|
|
Leucine, 4,5-dihydroxy- (9CI)
|
105817-05-8
|
C6H13NO4
|
|
Pentonic acid, 2-amino-2,3-dideoxy-3-methyl- (9CI)
|
105817-06-9
|
C6H13NO4
|
|
Anthraergosta-5,7,9,22-tetren-3-ol hexahydrobenzoate
|
105819-17-8
|
C35H52O2
|
|
3'-(2,2,5,5-tetramethylpyrroline-1-oxyl-3-carbonyl)amino-3'-deoxyguanosine 5'-triphosphate
|
105822-89-7
|
|
|
1',2'-dimethylheptyl-1-deoxy-delta(8)-tetrahydrocannabinol
|
105823-04-9
|
C25H38O
|
|
Tropisetron hydrochloride
|
105826-92-4
|
C17H21ClN2O2
|
|
3-Methoxy-2-(2-methoxyphenyl)- 4H-1-benzopyran-4-one
|
105827-35-8
|
C17H14O4
|
|
1,3-Cyclohexadiene-1-carboxylicacid,2,4-dimethyl-(9CI)
|
105827-63-2
|
C9H12O2
|
|
5-(Bromomethyl)-2-fluoropyridine
|
105827-74-5
|
C6H5BrFN
|
|
Admire
|
105827-78-9
|
C9H10ClN5O2
|
|
2-[[(6-Chloro-3-pyridinyl)methyl]amino]-ethanol
|
105827-84-7
|
C8H11ClN2O
|
|
Ethanethiol, 2-[[(5-methylpyrazinyl)methyl]amino]- (9CI)
|
105827-86-9
|
C8H13N3S
|
|
2-Nitroiminothiazolidine
|
105827-90-5
|
C3H5N3O2S
|
|
2-Chloro-5-chloromethylthiazole
|
105827-91-6
|
C4H3Cl2NS
|
|
IMIDACLOPRID IMPURITY 1
|
105828-41-9
|
C15H14Cl2N6O2
|
|
1,2-Ethanediamine,N-[(3-methyl-5-isoxazolyl)methyl]-(9CI)
|
105829-37-6
|
C7H13N3O
|
|
3-(N-hydroxycarboxamido-2-benzylpropanoyl)phenylalanine
|
105831-46-7
|
C20H22N2O5
|
|
Diethyl 2,6-dimethyl-4-pentyl-1,4-dihydropyridine-3,5-dicarboxylate
|
105831-51-4
|
C18H29NO4
|
|
TSTU
|
105832-38-0
|
C9H16BF4N3O3
|
|
N(6)-2-(4-amino-3-iodophenyl)ethyladenosine
|
105834-00-2
|
C18H21IN6O4
|
|
(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound
|
105834-21-7
|
C20H22FNO3
|
|
15-KEDE
|
105835-44-7
|
C20H34O3
|
|
(R)-1-(2-Methoxyphenyl)propanol
|
105836-13-3
|
C10H14O2
|
|
(R)-1-(4-Methoxyphenyl)propanol
|
105836-14-4
|
C10H14O2
|
|
ethyl 2-fluoro-3-hydroxybenzoate
|
105836-28-0
|
C9H9FO3
|
|
ethyl 3-broMo-3,3-difluoropropanoate
|
105836-29-1
|
C5H7BrF2O2
|
|
3,5-dichloro-N-phenylBenzenamine
|
105836-68-8
|
C12H9Cl2N
|
|
2,8-dibromooxanthrene
|
105836-96-2
|
C12H6Br2O2
|
|
1,7-Dinitrophenazine
|
105836-99-5
|
C12H6N4O4
|
|
2,8-Dinitrophenazine
|
105837-00-1
|
C12H6N4O4
|
|
ethyl 7-bromo-2-oxo-2H-chromene-3-carboxylate
|
105837-04-5
|
C12H9BrO4
|
|
N-Boc-O-tosyl hydroxylamine
|
105838-14-0
|
C12H17NO5S
|
|
2-Chloro-N-(2,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-acetamide
|
105838-50-4
|
C12H20ClNO
|
|
1-(3-aminophenyl)-2-(methyl-propan-2-yl-amino)ethanol
|
105838-76-4
|
C12H20N2O
|
|
1-(3-aminophenyl)-2-(methyl-propyl-amino)ethanol
|
105838-77-5
|
C12H20N2O
|
|
Fatty acids, C16 and C18-unsatd., polymers with bisphenol A, Bu glycidyl ether, epichlorohydrin and triethylenetetramine
|
105839-18-7
|
|
|
Fatty acids, C18-unsatd., dimers, polymers with acetic acid, diethylenetriamine and ethylenediamine
|
105839-20-1
|
C5H5N5
|
|
Fatty acids, C18-unsatd., dimers, polymers with acetic acid and ethylenediamine
|
105839-21-2
|
|
|
Fatty acids, C18-unsatd., dimers, polymers with bisphenol A, epichlorohydrin and triethylenetetramine
|
105839-25-6
|
|
|
1H-Pyrido[2,3-b][1,4]oxazine(9CI)
|
105839-39-2
|
C7H6N2O
|
|
1-Oxyl-2,2,5,5,-tetramethyl-3-vinyl-△3-pyrroline
|
105843-07-0
|
C10H16NO*
|
|
IMidaclothiz
|
105843-36-5
|
C7H8ClN5O2S
|
|
REC BETA-ECGF (HUMAN)
|
105843-51-4
|
|
|
hemoglobin Sendagi
|
105843-53-6
|
|
|
Disperse yellow 227
|
105844-79-9
|
|
|
8-Hydroxyjulolidine-9-aldehyde
|
105847-59-4
|
C13H15NO2
|
|
5-(Benzyloxybenzyloxybenzyl)acyclouridine
|
105847-66-3
|
C28H28N2O6
|
|
2H-1-Benzopyran, 7-methoxy-3-nitro-2-phenyl-
|
105849-85-2
|
C16H13NO4
|
|
2-Furancarbonyl chloride, 5-(chloromethyl)- (9CI)
|
105850-77-9
|
C6H4Cl2O2
|